Content about Goldman Sachs Group

October 23, 2013

All or part of Safeway may be a target for a possible buyout, according to a Reuters report published Wednesday morning citing people familiar with the matter.

NEW YORK — All or part of Safeway soon may be a target for a possible buyout, according to a Reuters report published Wednesday morning citing people familiar with the matter. 

According to the report, several buyout firms, including Cerberus Capital Management, are exploring a deal for the supermarket chain currently valued at $8 billion. 

January 4, 2013

According to a Bloomberg report, Abbott Laboratories, Johnson & Johnson and Sanofi are all potential suitors for Bausch & Lomb's eye care business in a deal that could be valued as high as $10 billion.

NEW YORK — According to a Bloomberg report published Friday morning, Abbott Laboratories, Johnson & Johnson and Sanofi are all potential suitors for Bausch & Lomb's eye care business in a deal that could be valued as high as $10 billion. 

B&L is being shopped by private equity firm Warburg Pincus, which is working with Goldman Sachs Group, Bloomberg reported, and both Abbott and Sanofi have contracted financial advisors as well. 

Other companies who have been invited to bid include Merck and Pfizer.